DCOY
Price
$2.69
Change
-$0.04 (-1.47%)
Updated
Sep 11 closing price
Capitalization
1.78M
Intraday BUY SELL Signals
KYNB
Price
$7.97
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
32.27M
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DCOY vs KYNB

DCOY vs KYNB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DCOY vs. KYNB commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCOY is a Buy and KYNB is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYNB($32.3M) has a higher market cap than DCOY($1.78M). KYNB YTD gains are higher at: -9.226 vs. DCOY (-65.449). DCOY has higher annual earnings (EBITDA): -14.59M vs. KYNB (-21.41M). KYNB has more cash in the bank: 91.3M vs. DCOY (8.29M). KYNB has higher revenues than DCOY: KYNB (4.62M) vs DCOY (0).
DCOYKYNBDCOY / KYNB
Capitalization1.78M32.3M6%
EBITDA-14.59M-21.41M68%
Gain YTD-65.449-9.226709%
P/E Ratio0.02N/A-
Revenue04.62M-
Total Cash8.29M91.3M9%
Total Debt112KN/A-
FUNDAMENTALS RATINGS
DCOY vs KYNB: Fundamental Ratings
DCOY
KYNB
OUTLOOK RATING
1..100
5490
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9445
P/E GROWTH RATING
1..100
89100
SEASONALITY SCORE
1..100
1845

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KYNB's Valuation (4) in the null industry is in the same range as DCOY (6). This means that KYNB’s stock grew similarly to DCOY’s over the last 12 months.

KYNB's Profit vs Risk Rating (100) in the null industry is in the same range as DCOY (100). This means that KYNB’s stock grew similarly to DCOY’s over the last 12 months.

KYNB's SMR Rating (100) in the null industry is in the same range as DCOY (100). This means that KYNB’s stock grew similarly to DCOY’s over the last 12 months.

KYNB's Price Growth Rating (45) in the null industry is somewhat better than the same rating for DCOY (94). This means that KYNB’s stock grew somewhat faster than DCOY’s over the last 12 months.

DCOY's P/E Growth Rating (89) in the null industry is in the same range as KYNB (100). This means that DCOY’s stock grew similarly to KYNB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DCOYKYNB
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (DCOY: $2.69 vs. KYNB: $7.97)
Brand notoriety: DCOY and KYNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DCOY: 47% vs. KYNB: 89%
Market capitalization -- DCOY: $1.78M vs. KYNB: $32.27M
DCOY [@Biotechnology] is valued at $1.78M. KYNB’s [@Biotechnology] market capitalization is $32.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DCOY’s FA Score shows that 1 FA rating(s) are green while KYNB’s FA Score has 1 green FA rating(s).

  • DCOY’s FA Score: 1 green, 4 red.
  • KYNB’s FA Score: 1 green, 4 red.
According to our system of comparison, KYNB is a better buy in the long-term than DCOY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DCOY’s TA Score shows that 5 TA indicator(s) are bullish while KYNB’s TA Score has 4 bullish TA indicator(s).

  • DCOY’s TA Score: 5 bullish, 3 bearish.
  • KYNB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DCOY is a better buy in the short-term than KYNB.

Price Growth

DCOY (@Biotechnology) experienced а -3.24% price change this week, while KYNB (@Biotechnology) price change was -6.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

KYNB is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DCOY
Daily Signal:
Gain/Loss:
KYNB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARM264.7910.61
+4.17%
Arm Holdings plc
QMMM119.40N/A
N/A
QMMM Holdings Ltd
PTLO4.09-0.01
-0.24%
Portillo's
RAND10.55-0.05
-0.47%
Rand Capital Corp
AMAL47.87-0.65
-1.34%
Amalgamated Financial Corp

DCOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, DCOY has been loosely correlated with GRDX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if DCOY jumps, then GRDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DCOY
1D Price
Change %
DCOY100%
-1.47%
GRDX - DCOY
61%
Loosely correlated
-3.70%
ALXO - DCOY
35%
Loosely correlated
+2.11%
SNGX - DCOY
32%
Poorly correlated
-0.79%
VOR - DCOY
31%
Poorly correlated
-0.18%
ASBP - DCOY
30%
Poorly correlated
-0.66%
More

KYNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYNB has been loosely correlated with ACXP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KYNB jumps, then ACXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYNB
1D Price
Change %
KYNB100%
-0.06%
ACXP - KYNB
54%
Loosely correlated
N/A
HYPD - KYNB
48%
Loosely correlated
-2.79%
RNAC - KYNB
35%
Loosely correlated
-2.85%
KYTX - KYNB
33%
Loosely correlated
-1.22%
DCOY - KYNB
31%
Poorly correlated
-1.47%
More